BTC$80,701.94▲ 4.92%ETH$2,426.26▲ 7.27%USDT$0.9993▲ 0.04%BNB$718.69▲ 3.81%XRP$1.31▲ 4.38%USDC$1.00▲ 0.01%SOL$95.94▲ 4.58%TRX$0.3197▼ 0.83%FIGR_HELOC$1.05▲ 1.54%ZEC$1,305.37▲ 8.75%HYPE$84.10▲ 2.61%DOGE$0.0770▲ 4.33%XMR$118.70▲ 1.54%USDS$1.00▲ 0.02%WBT$77.97▲ 5.57%LINK$11.44▲ 5.54%LEO$9.36▲ 0.21%ADA$0.1971▲ 5.72%XLM$0.1681▲ 5.55%BCH$282.40▲ 4.52%NEAR$4.02▲ 6.70%UNI$7.64▲ 8.40%DAI$1.00▲ 0.01%USDE$1.00▲ 0.06%LTC$56.18▲ 5.65%RAIN$0.005979▼ 7.72%CC$0.1002▲ 3.92%AVAX$8.74▲ 4.38%SUI$0.9306▲ 6.20%USD1$0.9994▲ 0.04%GRAM$1.17▲ 1.23%XAUT$4,106.38▲ 3.72%HBAR$0.0729▲ 6.51%QNT$203.01▲ 6.80%USDG$1.00▲ 0.02%SHIB$0.000005▲ 4.10%TAO$236.30▲ 6.79%PYUSD$1.00▲ 0.02%CRO$0.0522▲ 5.10%RLUSD$1.00▲ 0.02%BTC$80,701.94▲ 4.92%ETH$2,426.26▲ 7.27%USDT$0.9993▲ 0.04%BNB$718.69▲ 3.81%XRP$1.31▲ 4.38%USDC$1.00▲ 0.01%SOL$95.94▲ 4.58%TRX$0.3197▼ 0.83%FIGR_HELOC$1.05▲ 1.54%ZEC$1,305.37▲ 8.75%HYPE$84.10▲ 2.61%DOGE$0.0770▲ 4.33%XMR$118.70▲ 1.54%USDS$1.00▲ 0.02%WBT$77.97▲ 5.57%LINK$11.44▲ 5.54%LEO$9.36▲ 0.21%ADA$0.1971▲ 5.72%XLM$0.1681▲ 5.55%BCH$282.40▲ 4.52%NEAR$4.02▲ 6.70%UNI$7.64▲ 8.40%DAI$1.00▲ 0.01%USDE$1.00▲ 0.06%LTC$56.18▲ 5.65%RAIN$0.005979▼ 7.72%CC$0.1002▲ 3.92%AVAX$8.74▲ 4.38%SUI$0.9306▲ 6.20%USD1$0.9994▲ 0.04%GRAM$1.17▲ 1.23%XAUT$4,106.38▲ 3.72%HBAR$0.0729▲ 6.51%QNT$203.01▲ 6.80%USDG$1.00▲ 0.02%SHIB$0.000005▲ 4.10%TAO$236.30▲ 6.79%PYUSD$1.00▲ 0.02%CRO$0.0522▲ 5.10%RLUSD$1.00▲ 0.02%

Phase Labs Staked SOL vs Lista DAO

Phase Labs Staked SOL (PHASESOL) and Lista DAO (LISTA) compared side by side.

Phase Labs Staked SOLPHASESOL

$114.4700

24h
—
Market cap
—
Volume 24h
—
Volatility (ann.)
—
Lista DAOLISTA

$0.077600

24h
+4.55%
Market cap
$33.19M
Volume 24h
$994,513
Volatility (ann.)
96%
PHASESOL 0.0%Share of the two combined market caps100.0% LISTA

Performance

PHASESOLLISTA

  1. 7 days-13.11%-2.39%LISTA
  2. 30 days—-8.26%—
  3. 90 days—+41.79%—
  4. 1 year—-66.91%—

Risk & extremes

MetricPHASESOLLISTA
Max drawdown (400d)-21.8%-91.7%
Risk-adjusted return (90d)—0.48
Best 30 days (past year)—+61.2%
Worst 30 days (past year)—-50.7%

Relative strength over 90 days: LISTA outperformed PHASESOL by 6.0% — measured on the PHASESOL/LISTA ratio, so it holds regardless of market direction.